Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 2, 2002, Pages 323-328

  Wu, Dongmei ^a   Meiring, Muriel ^a   Kotze, Harry F ^a   Deckmyn, Hans ^a   Cauwenberghs, Nancy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antithrombotic agents; Bleeding time; Cyclic flow reductions; Platelet glycoprotein Ib; Platelet glycoprotein IIb IIIa

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 16N7C2; MONOCLONAL ANTIBODY 6B4 FAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BABOON; BLEEDING TIME; CONTROLLED STUDY; DOSE RESPONSE; FEMORAL ARTERY; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; THROMBOGENESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL ARTERY; MALE; PAPIO; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOSIS;

EID: 0036162199     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0202.102321     Document Type: Article

References (27)

1. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling
2. Structural determinants within glycoprotein Ibalpha involved in its binding to von Willebrand factor
3. Pathophysiology of coronary occlusion in acute infarction
4. Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly from coronary artery disease
5. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model
6. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation
7. Prolonged inhibition of acute arterial thrombosis by high dosing of a monoclonal anti-platelet glycoprotein IIb/IIIa antibody in a baboon model
8. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors
9. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium
10. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates
11. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain
12. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster
13. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates
14. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibα
15. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis
16. Cyclic flow variations in a conscious dog model of coronary artery stenoses and endothelial injury correlate with acute ischemic heart disease syndromes in humans
17. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury
18. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function
19. Characterization of murine anti-GPIb monoclonal antibodies that differentiate between shear-induced and risto/botrocetininduced GPIb-vWF interaction
20. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor
21. Anti-human vWF monoclonal antibody, AJvW-2 Fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs
22. Effects of an antiplatelet glycoprotein Ib antibody on hemostatic function in the guinea pig
23. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor
24. Platelets and shear stress
25. A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions
26. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development
27. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus